Get started
Author

Caroline Lonez

Observed names: C LONEZ, C. Lonez, Lonez, C, Lonez, Caroline
Institution: Celyad (Belgium)
ORCID: 0000-0002-9230-3855
Observed ORCID: 0000-0002-9230-3855
OpenAlex ID: A5085579647
Cationic lipids activate intracellular signaling pathways
2012 · Caroline Lonez, Michel Vandenbranden, et al. · Advanced Drug Delivery Reviews · 232
Cationic liposomal lipids: From gene carriers to cell signaling
2008 · Caroline Lonez, Michel Vandenbranden, et al. · Progress in Lipid Research · 216
Role of lipid microdomains in TLR-mediated signalling
2015 · Jean-Marie Ruysschaert, Caroline Lonez · Biochimica et Biophysica Acta (BBA) - Biomembranes · 153
PDF
Cationic lipid nanocarriers activate Toll-like receptor 2 and NLRP3 inflammasome pathways
2013 · Caroline Lonez, Michel Bessodes, et al. · Nanomedicine Nanotechnology Biology and Medicine · 132
Long-term In Vitro Treatment of Human Glioblastoma Cells with Temozolomide Increases Resistance In Vivo through Up-regulation of GLUT Transporter and Aldo-Keto Reductase Enzyme AKR1C Expression
2010 · Benjamin Le Calvé, Michal Rynkowski, et al. · Neoplasia · 132
Allogeneic CAR-T Therapy Technologies: Has the Promise Been Met?
2024 · Caroline Lonez, Eytan Breman · Cells · 120
PDF
CYAD-01, an autologous NKG2D-based CAR T-cell therapy, in relapsed or refractory acute myeloid leukaemia and myelodysplastic syndromes or multiple myeloma (THINK): haematological cohorts of the dose escalation segment of a phase 1 trial
2023 · David A Sallman, Tessa Kerre, et al. · The Lancet Haematology · 111
DiC14‐amidine cationic liposomes stimulate myeloid dendritic cells through Toll‐like receptor 4
2008 · Tetsuya Tanaka, Amandine Legat, et al. · European Journal of Immunology · 100
NKG2D-based chimeric antigen receptor therapy induced remission in a relapsed/refractory acute myeloid leukemia patient
2018 · David A. Sallman, Jason Brayer, et al. · Haematologica · 82
PDF
Chimeric Antigen Receptor-T Cells for Targeting Solid Tumors: Current Challenges and Existing Strategies
2019 · Lorraine Springuel, Caroline Lonez, et al. · BioDrugs · 70
PDF
Saturation of acyl chains converts cardiolipin from an antagonist to an activator of Toll-like receptor-4
2019 · Malvina Pizzuto, Caroline Lonez, et al. · Cellular and Molecular Life Sciences · 70
PDF
Exploiting natural killer group 2D receptors for CAR T-cell therapy
2017 · Benjamin Demoulin, W. James Cook, et al. · Future Oncology · 58
PDF
Large supramolecular structures of 33-mer gliadin peptide activate toll-like receptors in macrophages
2018 · María Georgina Herrera, Malvina Pizzuto, et al. · Nanomedicine Nanotechnology Biology and Medicine · 52
Study protocol for THINK: a multinational open-label phase I study to assess the safety and clinical activity of multiple administrations of NKR-2 in patients with different metastatic tumour types
2017 · Caroline Lonez, Bikash Verma, et al. · BMJ Open · 50
PDF
Activation of innate immunity by lysozyme fibrils is critically dependent on cross-β sheet structure
2013 · Adelin Gustot, Vincent Raussens, et al. · Cellular and Molecular Life Sciences · 50
Updated data from alloSHRINK phase I first-in-human study evaluating CYAD-101, an innovative non-gene edited allogeneic CAR-T in mCRC.
2021 · Hans Prenen, Jeroen Dekervel, et al. · Journal of Clinical Oncology · 47
Critical residues involved in Toll-like receptor 4 activation by cationic lipid nanocarriers are not located at the lipopolysaccharide-binding interface
2015 · Caroline Lonez, Kate L. Irvine, et al. · Cellular and Molecular Life Sciences · 47
PDF
Self-assembly of 33-mer gliadin peptide oligomers
2015 · M. G. Herrera, L. A. Benedini, et al. · Soft Matter · 46
Cationic lipids as one-component vaccine adjuvants: A promising alternative to alum
2018 · Malvina Pizzuto, Pascal Bigey, et al. · Journal of Controlled Release · 40
PDF
Fusogenic activity of cationic lipids and lipid shape distribution
2009 · Caroline Lonez, Marc F. Lensink, et al. · Cellular and Molecular Life Sciences · 39
Lipid Mixing between Lipoplexes and Plasma Lipoproteins Is a Major Barrier for Intravenous Transfection Mediated by Cationic Lipids
2005 · Bouna-Moussa Tandia, Caroline Lonez, et al. · Journal of Biological Chemistry · 39
Results from the Completed Dose-Escalation of the Hematological Arm of the Phase I Think Study Evaluating Multiple Infusions of NKG2D-Based CAR T-Cells As Standalone Therapy in Relapse/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients
2019 · David A Sallman, Jason B. Brayer, et al. · Blood · 28
PDF
Toll-like receptor 2 promiscuity is responsible for the immunostimulatory activity of nucleic acid nanocarriers
2016 · Malvina Pizzuto, Monique Gangloff, et al. · Journal of Controlled Release · 28
PDF
Immunicy-1: Targeting BCMA with Cyad-211 to Establish Proof of Concept of an shRNA-Based Allogeneic CAR T Cell Therapy Platform
2021 · Ahmad-Samer Al-Homsi, Sebastien Anguille, et al. · Blood · 27
Remissions in Relapse/Refractory Acute Myeloid Leukemia Patients Following Treatment with NKG2D CAR-T Therapy without a Prior Preconditioning Chemotherapy
2018 · David A Sallman, Tessa Kerre, et al. · Blood · 27
Works count: 84
Citation count: 2,404
H-index: 26
I10-index: 43
Year
Topic
Type